IXHL — Incannex Healthcare Cashflow Statement
0.000.00%
- $6.16m
- $0.85m
- $0.01m
Annual cashflow statement for Incannex Healthcare, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | C2021 June 30th | 2022 June 30th | R2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | 10-K | 10-K |
Standards: | IFRS | IFRS | IFRS | USG | USG |
Status: | fx Final | fx Final | fx Final | Final | Final |
Changes in Working Capital | 0.002 | 0.002 | 0.005 | -10.7 | -15.8 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.62 | -5.15 | -9.29 | -10.7 | -15.8 |
Capital Expenditures | 0 | — | — | -0.316 | -0.277 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.009 | 0.022 | 0 | — | — |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Cash from Investing Activities | 0.009 | 0.022 | 0 | -0.316 | -0.277 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 4.96 | 9.25 | 29.9 | 8.18 | 0 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.35 | 4.12 | 20.6 | -3.71 | -16.3 |